Results 161 to 170 of about 36,270 (220)

Effect of 7 and 13-Valent Pneumococcal Conjugate Vaccines Different Number of Doses for Pneumonia Control in 2008 and 2010 Birth Cohort Children

, 2015
María Hortal, Miguel Meny, Miguel Estevan, Fernando Arrieta, Hilda Laurani   +4 more
openalex   +2 more sources

Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial. [PDF]

N Engl J Med
Gallagher KE, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, Mwalekwa L, Ragab S, Twi-Yeboah L, Berkley JA, Hamaluba M, Karani A, Shangala J, Otiende M, Gardiner E, Mugo D, Smith PG, Tabu C, Were F, Goldblatt D, Scott JAG.   +20 more
europepmc   +1 more source

Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso. [PDF]

Vaccine
Childs L, Zoma RL, Ouedraogo I, Sawadogo G, Tarbangdo TF, Zoma A, Ouangraoua S, Dama E, Tran T, Akhter F, Utreja S, Ouattara M, Verani JR, Sanou S, Aké HF, McGee L, Kobayashi M.   +16 more
europepmc   +1 more source

The Divergent Effect of Different Infant Vaccination Schedules of the 13-Valent Pneumococcal Conjugate Vaccine on Serotype-Specific Immunological Memory [PDF]

Irene Tzovara, Ioanna Papadatou, Marianna Tzanoudaki, Christina Piperi, Christina Kanaka‐Gantenbein, Vana Spoulou   +5 more
openalex   +1 more source

The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children. [PDF]

PLOS Glob Public Health
Haeusler IL, Kagucia EW, Bottomley C, Otiende M, Nyiro J, Scott JAG.   +5 more
europepmc   +1 more source

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population. [PDF]

Infect Dis Ther
Fiévez S, Ta A, Bellier L, Blanc E, El Khoury JY, Beillat M, Sabra A, Sivignon M, Ilic A, Perdrizet J.   +9 more
europepmc   +1 more source

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

, 2010
Fiona M. Russell, Paul V. Licciardi, Anne Balloch, V. Biaukula, Lisi Tikoduadua, Jonathan R. Carapetis, Jane Nelson, Adam Jenney, Lepani Waqatakirewa, Samantha Colquhoun, Yin Bun Cheung, Mimi L.K. Tang, Kim Mulholland   +12 more
openalex   +2 more sources

Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus. [PDF]

Lupus Sci Med
Chatterjee R, Kommaraju SY, Mettingal Ramakrishnan S, Ravikumar KL, Aggarwal A.   +4 more
europepmc   +1 more source

Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006–2014

, 2017
Alane Izu, Fatima Solomon, Susan Nzenze, Azwifarwi Mudau, Elizabeth R. Zell, Katherine L. O’Brien, Cynthia G. Whitney, Jennifer R. Verani, Michelle J. Groome, Shabir A. Madhi   +9 more
openalex   +1 more source

Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016

, 2019
Claire von Mollendorf, Sophie La Vincente, Mukhchuluun Ulziibayar, Bujinlkham Suuri, Dashtseren Luvsantseren, Dorj Narangerel, John de Campo, Margaret de Campo, Cattram Nguyen, Sodbayar Demberelsuren, Tuya Mungun, Kim Mulholland   +11 more
openalex   +2 more sources